认知功能障碍的早期识别和筛查(6)
[25] Mattsson N， Zetterberg H， Hansson O， et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment [J]. JAMA， 2009， 302(4)： 385-393.
[26] Mitchell AJ. CSF phosphorylated tau in the prognosis and diagnosis of mild cognitive impairment and Alzheimer’s disease： a meta-analysis of 51 studies [J]. J Neurol Neurosurg Psychiatry， 2009， 80(9)： 966-975.
[27] Ritchie C， Smailagic N， Noel-Storr AH， et al. CSF tau and the CSF tau/Aβ ratio for the diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) [J/OL]. Cochrane Database Syst Rev， 2017， 3： CD010803 [2017-04-17]. http：//dx.doi. org/10.1002/14651858.CD010803.pub2.
[28] Greicius MD， Srivastava G， Reiss AL， et al. Default-mode network activity distinguishes Alzheimer’s disease from healthy aging： evidence from functional MRI [J]. Proc Natl Acad Sci U S A， 2004， 101(13)： 4637-4642.
[29] Johnson KA， Fox NC， Sperling RA， et al. Brain imaging in Alzheimer disease [J/OL]. Cold Spring Harb Perspect Med， 2012， 2(4)： a006213 [2017-04-17]. http：// perspectivesinmedicine.cshlp.org/content/2/4/a006213.full. pdf+html.
[30] Chien DT， Bahri S， Szardenings AK， et al. Early clinical PET imaging results with the novel PHF-tau radioligand[F-18]-T807 [J]. J Alzheimers Dis， 2013， 34(2)： 457-468. (龚骊 方珉)
[26] Mitchell AJ. CSF phosphorylated tau in the prognosis and diagnosis of mild cognitive impairment and Alzheimer’s disease： a meta-analysis of 51 studies [J]. J Neurol Neurosurg Psychiatry， 2009， 80(9)： 966-975.
[27] Ritchie C， Smailagic N， Noel-Storr AH， et al. CSF tau and the CSF tau/Aβ ratio for the diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) [J/OL]. Cochrane Database Syst Rev， 2017， 3： CD010803 [2017-04-17]. http：//dx.doi. org/10.1002/14651858.CD010803.pub2.
[28] Greicius MD， Srivastava G， Reiss AL， et al. Default-mode network activity distinguishes Alzheimer’s disease from healthy aging： evidence from functional MRI [J]. Proc Natl Acad Sci U S A， 2004， 101(13)： 4637-4642.
[29] Johnson KA， Fox NC， Sperling RA， et al. Brain imaging in Alzheimer disease [J/OL]. Cold Spring Harb Perspect Med， 2012， 2(4)： a006213 [2017-04-17]. http：// perspectivesinmedicine.cshlp.org/content/2/4/a006213.full. pdf+html.
[30] Chien DT， Bahri S， Szardenings AK， et al. Early clinical PET imaging results with the novel PHF-tau radioligand[F-18]-T807 [J]. J Alzheimers Dis， 2013， 34(2)： 457-468. (龚骊 方珉)